Word

MILTENYI

Status

Registered

Status Code

706

Status Date

Tuesday, March 29, 2022

Serial Number

79154057

Registration Number

4838794

Registration Date

Tuesday, October 27, 2015

Mark Type

4000

Filing Date

Monday, March 31, 2014

Published for Opposition

Tuesday, August 11, 2015

Trademark Owner History

Miltenyi Biotec B.V. & Co. KG -
Miltenyi Biotec GmbH - Original Registrant

Classifications

9 Scientific, optical and measuring apparatus and instruments, namely, laboratory apparatus and instruments for the separation, analysis, processing and cultivation of biological material; apparatus for recording, transmission or reproduction of images, data processing equipment, computer software for controlling and managing of blood and blood elements information, computer software for use in operating equipment for the separation, analysis, processing and cultivation of biological material, scientific, electrical and electronic laboratory apparatus and instruments for conducting enzymatic reactions; laboratory equipment, in particular cytometer for measuring physical and/or chemical properties of cells and other particles in suspensions

5 Pharmaceutical, medical and veterinary preparations, namely, diagnostic preparations for medical and veterinary use for the purpose of early recognition or characterization of diseases; pharmaceutical and other preparations, namely, diagnostic preparations for medical or veterinary use for the purpose of early recognition or characterization of diseases; reagents, contrast media and diagnostic agents for the preparation of media, all for medical or veterinary purposes; reagents for the processing, separation, isolation, enrichment, depletion, detection, screening, analysis and counting of material, especially of biological materials, reagents with magnetic beads, antibody reagents, all for medical or veterinary purposes; disinfectants for medical instruments in the nature of buffer solutions and reagents for use with medical instruments, especially separation instruments, analysis instruments, reactor and imaging instruments; reagents for the processing of biological material, especially tissue, bone marrow, cells, blood and its components, all for medical or veterinary purposes; culture media for cultivating and maturing stem cells, tissue cells, immune cells and microorganisms for medical purposes; diagnostic reagents and preparations for medical and veterinary purposes; cryopreservation cell freezing media, contrast agents, contrast agents for in-vivo imaging, all for medical and veterinary purposes; pharmaceutical products, namely, pharmaceutical products for the cellular therapy treatment of cancer, autoimmunity, infection and inflammation and other tissue-based diseases, immunological, dermatological and neurological diseases; chemical, biological and biochemical products for therapeutic and diagnostic purposes, namely, diagnostic preparations made from chemicals and biochemicals for medical purposes for the treatment of cancer and biological preparations for the therapeutic treatment of cancer, autoimmunity, dermatology, neurological and cardiovascular diseases

1 Chemical, biological and biochemical products for industrial and scientific purposes, other than for medical purposes, namely, biological tissue cultures for industrial and scientific purposes and not for medical or veterinary purposes; chemical products, namely, chemical additives for use in separation processes for biological materials; chemical, biochemical and diagnostic reagents for cell separation, labelling chemical, biochemical and diagnostic reagents, reagents, cell culture media for growing cells, tempering substances and chemical ingredients for the preparation of media, all for non-medical commercial and scientific purposes and for the use in medical research laboratories; chemical, biochemical and diagnostic reagents for non-medical purposes for the processing, separation, isolation, enrichment, depletion, detection, screening, analysis and counting of materials, especially of chemical and biological material; chemical, biochemical and diagnostic reagents for non-medical purposes with magnetic beads; antibody reagents other than for medical or veterinary purposes; chemical buffer solutions and reagents for use with laboratory instruments, especially separation instruments, analysis instruments, reactors and imaging instruments; reagents for processing of biological material, especially tissue, bone marrow, cells, blood and its components other than for medical or veterinary purposes; diagnostic reagents and preparations for scientific purposes and for use in medical laboratories; biological tissue culture media, cell culture media, cryogenic chemical preparations for use in the freezing of genetic and blood tissue, contrast agents, contrast agents for in-vivo imaging, all for scientific purposes; chemical, biochemical and diagnostic reagents for use in biotechnology, in biological treatment processes and in the biotechnology industry for non-medical purposes

44 Medical, pharmaceutical and biotechnological laboratory services relating to the treatment of persons and animals; medical services, in particular the field of extracorporeal plasma therapy

10 Surgical, medical, dental and veterinary apparatus and instruments for use in general surgery; apparatus for magnetic cell separation for medical purposes; drainage and transfusion tubing sets for medical purposes; medical diagnostic apparatus in the nature of columns for blood analysis for medical purposes; sacks, bags, sheets, tubes and connectors for surgical, medical, scientific or veterinary purposes, in particular for tissue and blood collection for cryopreservation; surgical apparatus and instruments for medical and surgical purposes; spare parts for the aforesaid goods

42 Scientific and technological services and research and design services relating hereto, namely, scientific research and design of medical and laboratory equipment; industrial laboratory analysis and research services; design and development of computer hardware and software for the analysis, all of the aforementioned services for and in connection with the analysis of biological and biochemical material, especially of cellular material for biological and medical research and therapy; medical and pharmaceutical laboratory services for research, analysis and development of new products specifically directed toward manufactured products in the fields of cell therapeutic agents, cell compounds, cell preparation, cellular medicines, kits, reagents, and the selection, stimulation, activation of cells

Trademark Events

Mar 29, 2022

Notice Of Acceptance Of Sec. 71 - E-Mailed

Mar 29, 2022

Registered-Sec.71 Accepted

Mar 29, 2022

Case Assigned To Post Registration Paralegal

Aug 20, 2021

Teas Section 71 Received

Oct 27, 2020

Courtesy Reminder - Sec. 71 (6-Yr) E-Mailed

Feb 20, 2020

New Representative At Ib Received

Dec 5, 2019

Change Of Owner Received From Ib

Mar 25, 2016

Final Decision Transaction Processed By Ib

Mar 7, 2016

Final Disposition Notice Sent To Ib

Mar 7, 2016

Final Disposition Processed

Jan 27, 2016

Final Disposition Notice Created, To Be Sent To Ib

Oct 27, 2015

Registered-Principal Register

Aug 21, 2015

Notification Processed By Ib

Aug 11, 2015

Official Gazette Publication Confirmation E-Mailed

Aug 11, 2015

Published For Opposition

Aug 5, 2015

Notification Of Possible Opposition Sent To Ib

Aug 5, 2015

Notice Of Start Of Opposition Period Created, To Be Sent To Ib

Jul 22, 2015

Notification Of Notice Of Publication E-Mailed

Jul 7, 2015

Law Office Publication Review Completed

Jul 1, 2015

Approved For Pub - Principal Register

Jun 18, 2015

Examiner's Amendment Entered

Jun 18, 2015

Notification Of Examiners Amendment E-Mailed

Jun 18, 2015

Examiners Amendment E-Mailed

Jun 18, 2015

Examiners Amendment -Written

Jun 13, 2015

Teas/Email Correspondence Entered

Jun 12, 2015

Correspondence Received In Law Office

Jun 12, 2015

Teas Request For Reconsideration Received

May 15, 2015

Notification Of Final Refusal Emailed

May 15, 2015

Final Refusal E-Mailed

May 15, 2015

Final Refusal Written

May 14, 2015

Teas/Email Correspondence Entered

May 14, 2015

Correspondence Received In Law Office

May 13, 2015

Assigned To Lie

May 11, 2015

Teas Response To Office Action Received

May 11, 2015

Attorney/Dom.Rep.Revoked And/Or Appointed

May 11, 2015

Teas Revoke/App/Change Addr Of Atty/Dom Rep Received

Nov 28, 2014

Refusal Processed By Ib

Nov 12, 2014

Non-Final Action Mailed - Refusal Sent To Ib

Nov 12, 2014

Refusal Processed By Mpu

Nov 8, 2014

Application Filing Receipt Mailed

Nov 7, 2014

Non-Final Action (Ib Refusal) Prepared For Review

Nov 6, 2014

Non-Final Action Written

Nov 4, 2014

Assigned To Examiner

Nov 4, 2014

New Application Office Supplied Data Entered In Tram

Oct 30, 2014

Sn Assigned For Sect 66a Appl From Ib